• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“谨慎”饮食和氯贝丁酯对IIa型高脂蛋白血症中载脂蛋白B的影响(作者译)

[Influence of "prudent" diet and clofibrate upon apolipoprotein B in hyperlipoproteinemia type IIa (author's transl)].

作者信息

Mertz D P, Suermann I, Göhmann E

出版信息

Med Klin. 1979 Feb 23;74(8):279-83.

PMID:216895
Abstract

If patients with hyperlipoproteinemia type IIa are treated with diet and additionally over a period of two weeks with 2 grams of Clofibrate daily, the cholesterol-level in the serum decreases. This decrease is caused mainly by a reduction of the apolipoprotein B and the LDL-cholesterol in serum. If elevated cholesterol-levels in the serum are reduced through a "prudent" diet, the concentration of apolipoprotein B in serum remains the same. It is not fully understood which influence a diet, which is rich in poly-unsaturated fatty acids and has a low content of saturated fatty acids and carbohydrates, has upon the lipoproteins in the serum. The mode of action of this diet and its significance for the concentration of HDL need further investigation.

摘要

如果IIa型高脂蛋白血症患者接受饮食治疗,并在两周内每天额外服用2克氯贝丁酯,血清中的胆固醇水平会降低。这种降低主要是由于血清中载脂蛋白B和低密度脂蛋白胆固醇的减少所致。如果通过“谨慎”饮食降低血清中升高的胆固醇水平,血清中载脂蛋白B的浓度保持不变。富含多不饱和脂肪酸、饱和脂肪酸和碳水化合物含量低的饮食对血清中的脂蛋白有何种影响尚不完全清楚。这种饮食的作用方式及其对高密度脂蛋白浓度的意义需要进一步研究。

相似文献

1
[Influence of "prudent" diet and clofibrate upon apolipoprotein B in hyperlipoproteinemia type IIa (author's transl)].“谨慎”饮食和氯贝丁酯对IIa型高脂蛋白血症中载脂蛋白B的影响(作者译)
Med Klin. 1979 Feb 23;74(8):279-83.
2
[Clofibrate in type IIa hyperlipoproteinemia. Reduction of apolipoprotein B (author's transl)].氯贝丁酯治疗IIa型高脂蛋白血症。载脂蛋白B的降低(作者译)
MMW Munch Med Wochenschr. 1978 Aug 25;120(34):1097-9.
3
[Treatment of hyperlipoproteinemia type IIa with a "prudent" diet and clofibrate (author's transl)].用“谨慎”饮食和氯贝丁酯治疗Ⅱa型高脂蛋白血症(作者译)
Med Klin. 1978 Jun 9;73(23):867-73.
4
[Hyperlipoproteinemia type IIa. Serum lipoprotein pattern as influenced by diet and clofibrate].[IIa型高脂蛋白血症。饮食和氯贝丁酯对血清脂蛋白模式的影响]
MMW Munch Med Wochenschr. 1979 Jun 8;121(23):791-2.
5
[Comparison between combination therapy with clofibrate and beta-pyridylcarbinol and clofibrate monotherapy (author's transl].安妥明与β-吡啶甲醇联合疗法和安妥明单一疗法的比较(作者译)
MMW Munch Med Wochenschr. 1978 Apr 14;120(15):525-8.
6
[The effect of etofibrate on serum cholesterol and triglycerides (author's transl)].益多酯对血清胆固醇及甘油三酯的影响(作者译)
Med Klin. 1979 Jun 1;74(22):875-6.
7
[Beclobrate (Turec) in the treatment of primary hyperlipoproteinemia. II. Results of the treatment in relation to the type of hyperlipoproteinemia].[氯贝酸(图雷克)治疗原发性高脂蛋白血症。II. 治疗结果与高脂蛋白血症类型的关系]
Przegl Lek. 1990;47(10):711-4.
8
[Clofibrate therapy in hypercholesterolemia. Reports on medium-long-term movements of HDL- cholesterol by the action of clofibrate].[氯贝丁酯治疗高胆固醇血症。关于氯贝丁酯作用下高密度脂蛋白胆固醇中长期变化的报告]
Fortschr Med. 1980 Dec 4;98(45):1761-6.
9
Hypercholesterolemia in ExHC rats and lipid-lowering drug: a screening method for new hypocholesterolemic agents.ExHC大鼠的高胆固醇血症与降脂药物:一种新型降胆固醇药物的筛选方法。
Artery. 1981;9(6):414-24.
10
[Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].[氯贝丁酯-烟酸肌醇酯联合用药对IIa型、IV型和V型原发性高脂蛋白血症患者血脂及脂蛋白的影响]
Arzneimittelforschung. 1983;33(5):776-9.